Venous thromboembolism (VTE) includes both deep vein thrombosis (DVT) and pulmonary
embolism. The 2009 JUPITER trial showed a significant decrease in DVT in non-hyperlipidemic
patients, with elevated C-reactive protein (CRP) levels, treated with rosuvastatin. The effects of
statins on thrombosis are unclear, prompting this literature review.